Related references
Note: Only part of the references are listed.Inflammatory cytokines in vascular dysfunction and vascular disease
Alexander H. Sprague et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1
Robert C. Carlisle et al.
BLOOD (2009)
Cetuximab Retargeting of Adenovirus via the Epidermal Growth Factor Receptor for Treatment of Intraperitoneal Ovarian Cancer
Joanne Morrison et al.
HUMAN GENE THERAPY (2009)
Adenovirus serotype 5 hexon mediates liver gene transfer
Simon N. Waddington et al.
CELL (2008)
Endothelial cells of human colorectal cancer and healthy colon reveal phenotypic differences in culture
Vera Simone Schellerer et al.
LABORATORY INVESTIGATION (2007)
Targeting selectins and selectin ligands in inflammation and cancer
Steven R. Barthel et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2007)
Incorporation of a laminin-derived peptide (SIKVAV) on polymer-modified adenovirus permits tumor-specific targeting via α6-integrins
M. Stevenson et al.
CANCER GENE THERAPY (2007)
Synthesis and properties of new N-(2-hydroxypropyl)-methacrylamide copolymers containing thiazolidine-2-thione reactive groups
V. Subr et al.
REACTIVE & FUNCTIONAL POLYMERS (2006)
Death receptor-3, a new E-selectin counter-receptor that confers migration and survival advantages to colon carcinoma cells by triggering p38 and ERK MAPK activation
Stephanie Gout et al.
CANCER RESEARCH (2006)
CD43 is a ligand for E-selectin on CLA+ human T cells
RC Fuhlbrigge et al.
BLOOD (2006)
Nanoparticles for the optical imaging of tumor E-selectin
M Funovics et al.
NEOPLASIA (2005)
Cytokine-mediated downregulation of coxsackievirus-adenovirus receptor in endothelial cells
T Vincent et al.
JOURNAL OF VIROLOGY (2004)
Extended plasma circulation time and decreased toxicity of polymer-coated adenovirus
NK Green et al.
GENE THERAPY (2004)
A novel strategy to modify adenovirus tropism and enhance transgene delivery to activated vascular endothelial cells in vitro and in vivo
KI Ogawara et al.
HUMAN GENE THERAPY (2004)
Delivery of pharmacologically active dexamethasone into activated endothelial cells by dexamethasone-anti-E-selectin immunoconjugate
SA Asgeirsdóttir et al.
BIOCHEMICAL PHARMACOLOGY (2003)
Antibody targeted gene transfer to endothelium
PH Tan et al.
JOURNAL OF GENE MEDICINE (2003)
Importance of lateral and steric stabilization of polyelectrolyte gene delivery vectors for extended systemic circulation
D Oupicky et al.
MOLECULAR THERAPY (2002)
CD44 is a major E-selectin ligand on human hematopoietic progenitor cells
CJ Dimitroff et al.
JOURNAL OF CELL BIOLOGY (2001)
Pharmacological aspects of targeting cancer gene therapy to endothelial cells
HH Sedlacek
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2001)
Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies
KD Fisher et al.
GENE THERAPY (2001)
Stimulatory and inhibitory action of cytokines on the regulation of hCMV-IE promoter activity in human endothelial cells
T Ritter et al.
CYTOKINE (2000)
Share Paper
